文献速递胃肠动力与功能性疾病消化内镜

优化全科消化科烧心管理算法:成本效果与成本最小化分析

Optimizing the Management Algorithm for Heartburn in General Gastroenterology: Cost-Effectiveness and Cost-Minimization Analysis.
PubMed 文献 · Clin Gastroenterol Hepatol · 2023-09-07

研究从保险方与患者视角构建决策分析模型,比较质子泵抑制剂(PPI)经验性治疗失败后4种策略的1年成本与健康结局。结果显示,PPI停药下内镜联合动态反流监测的表型管理策略最有效,每年增加22个健康日,并为保险方节省2183美元、为患者节省2396美元。

要点

  • 对于PPI经验性治疗失败的烧心患者,内镜联合动态反流监测(停用PPI)成本效果最优。
  • 无糜烂性发现时,尝试停用PPI比优化PPI更具成本效果。
  • 内镜发现糜烂性反流病可指导PPI优化,增加健康日并降低保险方成本。

核心结论

  • 在烧心患者中,停用PPI行内镜联合动态反流监测可通过表型匹配治疗优化成本效果管理。
  • 无糜烂性发现时,尝试停用PPI比优化PPI更具成本效果。

研究设计与样本

  • 决策分析模型,从保险方和患者视角比较PPI经验性治疗失败后4种策略,时间跨度1年,所有检测均在停用PPI下进行。

主要发现

  • 无检测的PPI优化因工作效率降低和症状缓解不理想,保险方成本为3784美元/年,患者成本为3128美元/年。
  • 内镜联合PPI优化通过识别糜烂性反流病,使保险方成本每年降低1020美元,并每年增加11个健康日。
  • 内镜联合停用PPI通过识别无需PPI的无糜烂性反流病患者,每年额外增加11个健康日。
  • 内镜/动态反流监测联合PPI停药试验通过优化表型指导治疗,为最有效策略(每年增加22个健康日),并为保险方节省2183美元、为患者节省2396美元。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Heartburn is the most common symptom seen in gastroenterology practice. We aimed to optimize cost-effective evaluation and management of heartburn. METHODS: We developed a decision analytic model from insurer and patient perspectives comparing 4 strategies for patients failing empiric proton pump inhibitors (PPIs): (1) PPI optimization without testing, (2) endoscopy with PPI optimization for all patients, (3) endoscopy with PPI discontinuation when erosive findings are absent, and (4) endoscopy/ambulatory reflux monitoring with PPI discontinuation as appropriate for phenotypic management. Health outcomes were respectively defined on systematic reviews of clinical trials. Cost outcomes were defined on Centers for Medicare and Medicaid Services databases and commercial multipliers for direct healthcare costs, and national observational studies evaluating healthcare utilization. The time horizon was 1 year. All testing was performed off PPI. RESULTS: PPI optimization without testing cost $3784/y to insurers and $3128 to patients due to lower work productivity and suboptimal symptom relief. Endoscopy with PPI optimization lowered insurer costs by $1020/y and added 11 healthy days/y by identifying erosive reflux disease. Endoscopy with PPI discontinuation added 11 additional healthy days/y by identifying patients without erosive reflux disease that did not need PPI. By optimizing phenotype-guided treatment, endoscopy/ambulatory reflux monitoring with a trial of PPI discontinuation was the most effective of all strategies (gaining 22 healthy days/y) and saved $2183 to insurers and $2396 to patients. CONCLUSIONS: Among patients with heartburn, endoscopy with ambulatory reflux monitoring (off PPI) optimizes cost-effective management by matching treatment to phenotype. When erosive findings are absent, trialing PPI discontinuation is more cost-effective than optimizing PPI.

来源:Clin Gastroenterol Hepatol,查看原文。版权归原作者所有。

引用

  1. Shah ED, Chan WW, Jodorkovsky D, et al. Optimizing the Management Algorithm for Heartburn in General Gastroenterology: Cost-Effectiveness and Cost-Minimization Analysis. Clin Gastroenterol Hepatol. 2023. PMID: 37683879. doi:10.1016/j.cgh.2023.08.026

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。